NEDD9 and non-small cell lung carcinoma: The results reported here indicate a striking modifier function of NEDD9 on the activity of ATM kinase and related signaling in KRAS/TP53 mutated NSCLC, with its effects on the regulation of both DDR and EMT processes, sensitivity to DNA damaging modalities, and the survival of the patients.